# Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva

> **NCT00014599** · PHASE2 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 31 (actual)

## Conditions studied

- Vulvar Cancer

## Interventions

- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00014599
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2005-02
- **Final completion:** —
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2012-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014599, "Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00014599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*